Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

47.28 +1.88 (+4.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Twist Bioscience's Earnings Outlook
Via Benzinga
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
From Twist Bioscience Corporation
Via Business Wire
2 Cathie Wood Growth Stocks That Could Make You Richer
These two biotechs could be winning plays for aggressive investors. 
Via The Motley Fool
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Analyst Ratings for Twist Bioscience
Via Benzinga
Analyst Ratings for Twist Bioscience
Via Benzinga
Why Twist Bioscience Stock Is Tumbling Today
Twist Bioscience Corp (NASDAQ: TWST) reported  
Via Benzinga
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
From Twist Bioscience Corporation
Via Business Wire
Recap: Twist Bioscience Q2 Earnings
Via Benzinga
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
From Twist Bioscience Corporation
Via Business Wire
Earnings Preview: Twist Bioscience
Via Benzinga
Where Twist Bioscience Stands With Analysts
Via Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
Via Benzinga
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
Elliott Wave Technical Analysis: Twist Bioscience Corp. - Wednesday, May 10
Looking for shorts once we have signs wave (iv) is complete. 
Via Talk Markets
Twist Bioscience to Present at ITF World 2023
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
Cathie Wood is loading up on these biotech stocks. 
Via The Motley Fool
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For May 5, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
The iconic money manager with a penchant for aggressive growth is staying active as her exchange-traded funds bounce back in 2023. 
Via The Motley Fool
The 7 Best Biotech Stocks for Personalized Medicine Investors
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
From Twist Bioscience Corporation
Via Business Wire
NVIDIA To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Tuesday
Wells Fargo cut the price target for Marathon Oil Corporation (NYSE: MRO) from $40 to $38. Wells Fargo analyst Roger Read maintained an Overweight rating. Marathon Oil shares fell 0.3% to $24.72 in... 
Via Benzinga
Elliott Wave Technical Analysis: Twist Bioscience Corp. Friday, April 14
It has been moving perfectly ever since the last update. Looking for a continuation lower, even though it seems like we could be looking for support soon as we approach equality of (iii) vs. (i). 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.